Millipore Sigma Vibrant Logo

553008 Raf1 Kinase Inhibitor I - CAS 220904-83-6 - Calbiochem

概述

Replacement Information

重要规格表

CAS #Empirical Formula
220904-83-6C₁₅H₈Br₂INO₂

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
553008-1MGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      Description
      OverviewA potent, cell-permeable, reversible, and ATP-competitive cRAF1 kinase inhibitor (IC50 = 9 nM). Shows ≥100-fold selectivity for Raf kinase versus Cdk1, Cdk2, c-Src, ERK2, MEK, p38, Tie2, VEGFR2, and c-Fms. Predicted broad spectrum antitumor agents. A 10 mM (500 µg/96 µl) solution of Raf1 Inhibitor I (Cat. No. 553003) in DMSO is also available.
      Catalogue Number553008
      Brand Family Calbiochem®
      Synonyms5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone, GW 5074
      References
      ReferencesLackey, K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 223.
      Product Information
      CAS number220904-83-6
      ATP CompetitiveY
      FormDark orange solid
      Hill FormulaC₁₅H₈Br₂INO₂
      Chemical formulaC₁₅H₈Br₂INO₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCRAFI kinase
      Primary Target IC<sub>50</sub>9 nM
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.



      From Catalog:
      Desc. Field- added "Predicted broad spectrum antitumor agents.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      553008-1MGCN 04055977193404

      Documentation

      Raf1 Kinase Inhibitor I - CAS 220904-83-6 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      Raf1 Kinase Inhibitor I - CAS 220904-83-6 - Calbiochem 分析证书

      标题批号
      553008

      参考

      参考信息概述
      Lackey, K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 223.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision13-January-2010 RFH
      Synonyms5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone, GW 5074
      DescriptionA potent, cell-permeable, reversible, and ATP-competitive cRaf1 kinase inhibitor (IC50 = 9 nM). Shows ≥100-fold selectivity for Raf kinase versus Cdk1, Cdk2, c-src, ERK2, MEK, p38, Tie2, VEGFR2 and c-fms. cRaf1 inhibitors are predicted to be broad spectrum antitumor agents.
      FormDark orange solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number220904-83-6
      Chemical formulaC₁₅H₈Br₂INO₂
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (200 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.



      From Catalog:
      Desc. Field- added "Predicted broad spectrum antitumor agents.
      Toxicity Standard Handling
      ReferencesLackey, K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 223.